SAB Biotherapeutics, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from SAB Biotherapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 7, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 8, 2025

Earnings release8-K

Quarterly report10-Q

Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025

Feb 12, 2025

Transcript

Guggenheim SMID Cap Biotech Conference

Feb 6, 2025

Transcript

2024

Q4 2024

Mar 30, 2025

Annual report10-K

Earnings release8-K

Corporate Presentation

Nov 19, 2024

Slides

Q3 2024

Nov 6, 2024

Earnings release8-K

Study Update

Sep 9, 2024

Press release

Slides

Q2 2024

Aug 8, 2024

Earnings release8-K

Quarterly report10-Q

Q1 2024

May 20, 2024

Earnings release8-K

Quarterly report10-Q

2023

Q4 2023

Mar 29, 2024

Earnings release8-K

Q3 2023

Nov 14, 2023

Earnings release8-K

Quarterly report10-Q

Q2 2023

Aug 21, 2023

Earnings release8-K

Quarterly report10-Q

Study Update

Jun 22, 2023

Press release

Slides

Q1 2023

May 16, 2023

Earnings release8-K

Quarterly report10-Q

Corporate Presentation

May 3, 2023

Press release

Slides

2022

Q4 2022

Mar 31, 2023

Earnings release8-K

Q3 2022

Nov 15, 2022

Earnings release8-K

Quarterly report10-Q

Study Result

Nov 3, 2022

Press release

Slides

Investor Presentation

Oct 4, 2022

Slides

R&D Portfolio Update 2022

Aug 17, 2022

Slides

Q2 2022

Aug 10, 2022

Earnings release8-K

Quarterly report10-Q

Study Result

Jun 7, 2022

Slides

Q1 2022

May 12, 2022

Earnings release8-K

2021

Q4 2021

Mar 29, 2022

Earnings release8-K

Q3 2021

Nov 22, 2021

Earnings release8-K

Quarterly report10-Q

R&D Day 2021

Oct 13, 2021

Slides